Serevent Shortage Update: What Patients Need to Know in 2026

Patients and caregivers searching for Serevent Diskus (salmeterol xinafoate) in 2026 often wonder whether there's an official shortage. The short answer is no — but the longer answer explains why access can still be genuinely challenging. Here's a clear-eyed update on Serevent and related salmeterol product availability in 2026.

Current Status: No Active FDA Shortage for Serevent Diskus

As of 2026, Serevent Diskus manufactured by GlaxoSmithKline (GSK) is not listed on the FDA's official drug shortage database. The medication is in production and is generally available through wholesale distribution channels to pharmacies nationwide.

However, this does not mean every pharmacy has it on the shelf at all times. Serevent Diskus is a specialty brand-name inhaler with moderate demand compared to more commonly prescribed inhalers. Some pharmacies — particularly smaller independent locations — may not stock it routinely.

What Happened With AirDuo RespiClick?

A significant development affecting the salmeterol landscape was Teva Pharmaceuticals' discontinuation of all AirDuo RespiClick presentations — a fluticasone/salmeterol combination inhaler. Teva pulled the entire AirDuo line, which affected patients who had been using this as their ICS/LABA combination therapy.

This discontinuation does not directly affect Serevent Diskus, which is a standalone salmeterol inhaler made by GSK — a different manufacturer. However, it contributed to some confusion and increased demand on other salmeterol-containing products.

Why Patients Report Difficulty Finding Serevent

Even without a formal FDA shortage, three factors make Serevent Diskus difficult to access for many patients in 2026:

No generic available: As of March 2026, the FDA has not approved a generic form of Serevent Diskus. This keeps prices high — retail costs run $420–$557 per inhaler — and limits insurance formulary coverage.

Insurance restrictions: Many insurance plans require prior authorization, step therapy, or classify Serevent as a non-preferred Tier 3 or Tier 4 brand. This effectively creates a coverage wall that can feel like a shortage to patients who can't afford the cash price.

Pharmacy-level stocking gaps: Because Serevent is not the highest-volume seller, individual pharmacies may not maintain consistent stock. One location may be out while another nearby has it.

A Brief History of Salmeterol Availability

Salmeterol was first approved by the FDA in 1994. Since then, the primary clinical debate has not been about supply, but about safety: the black box warning about asthma-related death risk when LABAs are used without ICS led to changes in prescribing guidelines. The Salmeterol Multicenter Asthma Research Trial (SMART) established that salmeterol monotherapy in asthma carries increased mortality risk, which is why Serevent is now always prescribed alongside an ICS for asthma patients.

From a supply standpoint, Serevent Diskus has not had major shortage events in its history as a GSK product. The AirDuo RespiClick discontinuation was a Teva decision affecting a different salmeterol-containing product.

What Should Patients Do Right Now?

If you are a Serevent patient in 2026, here's what we recommend:

Don't wait until you run out. Reorder Serevent with at least a week or two of supply remaining, especially if your pharmacy needs to special-order it.

Use medfinder if your pharmacy is out — it calls nearby pharmacies and finds which ones can fill your prescription.

Check your insurance coverage. If your plan doesn't cover Serevent, ask your doctor about filing a prior authorization or about a covered alternative.

Use the GSK $35 coupon (commercially insured patients) or apply for GSK Access (uninsured/underinsured). Both can dramatically reduce your out-of-pocket cost.

Consider mail-order pharmacy for greater supply reliability on a 90-day basis.

The Bottom Line for 2026

Serevent Diskus is not in a national shortage, but it's not easy to access for everyone. Insurance barriers and the lack of a generic version are the main obstacles in 2026. If you can't fill your prescription, review your savings options, try medfinder to find a stocked pharmacy, and talk to your doctor about whether an alternative would work for you. See our full guide: Alternatives to Serevent.